Skip to content

NAMS - NewAmsterdam Pharma Co N.V. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchN

NewAmsterdam Pharma Company N.V. Ordinary Shares

NAMS · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

N

NAMSNewAmsterdam Pharma Company N.V. Ordinary Shares

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 20

52-wk high: $42.20
52-wk low: $23.05
Prev close: $33.68
Mkt cap: $3.34B
Beta: 0.11
P/S: 468.4x

Smart money

8 funds hold a position and insiders have been net selling.

Real smart money

Funds holding this stock

8 holders

Combined position$828.9M

VG
Viking Global
Andreas Halvorsen · Q2 2026 13F
$142.5M
position
MC
Maverick Capital

Earnings

Reported Aug 5, 2026

Earnings came in 8.3% below what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $3.3B

Valuation

P/S468.37
P/B5.16

Quality

Operating margin-1753.0%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: NAMS
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $3.34B
Beta: 0.11

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

P/B

5.2x

Profit margin

+0.0%

Op margin

-1753.0%

ROE

-36.8%

Lee Ainslie · Q2 2026 13F

$110.7M

position

SD

Stanley Druckenmiller

Q2 2026 13F

$104.0M

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for NAMS

No recent Congress trade
No recent market-voice mention

Earnings per share

-$0.52-8.3%

-$0.48 expected

Next report

What the street expects next

EPS expected

-$0.48

-$0.51 to -$0.39

Revenue expected

$0.00

6 analysts

Last 30 days

0up1down

Analysts cutting estimates

Estimate drift

0.06

Change in 30 days

-36.8%

ROA-20.1%

Growth

Beta0.11